RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer

RAS mutant (MT) metastatic colorectal cancer (mCRC) is resistant to MEK1/2 inhibition and remains a difficult-to-treat group. Therefore, there is an unmet need for novel treatment options for RAS MT mCRC. RALA and RALB GTPases function downstream of RAS and have been found to be key regulators of se...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease Vol. 11; no. 10; p. 930
Main Authors: Khawaja, Hajrah, Campbell, Andrew, Roberts, Jamie Z., Javadi, Arman, O’Reilly, Paul, McArt, Darragh, Allen, Wendy L., Majkut, Joanna, Rehm, Markus, Bardelli, Alberto, Di Nicolantonio, Federica, Scott, Christopher J., Kennedy, Richard, Vitale, Nicolas, Harrison, Timothy, Sansom, Owen J., Longley, Daniel B., Evergren, Emma, Van Schaeybroeck, Sandra
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 29.10.2020
Springer Nature B.V
Nature Publishing Group
Subjects:
ISSN:2041-4889, 2041-4889
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first